Laboratorio Reig Jofre, S.A.

LSE:0RB1 Stock Report

Market Cap: €225.8m

Laboratorio Reig Jofre Future Growth

Future criteria checks 4/6

Laboratorio Reig Jofre is forecast to grow earnings and revenue by 25.2% and 8.7% per annum respectively. EPS is expected to grow by 24% per annum. Return on equity is forecast to be 7% in 3 years.

Key information

25.2%

Earnings growth rate

24.0%

EPS growth rate

Pharmaceuticals earnings growth19.6%
Revenue growth rate8.7%
Future return on equity7.0%
Analyst coverage

Low

Last updated31 Oct 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0RB1 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026408179N/A1
12/31/2025379155N/A1
12/31/2024349112N/A1
9/30/202433410N/AN/AN/A
6/30/20243349-316N/A
3/31/20243269N/AN/AN/A
12/31/20233189619N/A
9/30/202331612N/AN/AN/A
6/30/202329810618N/A
3/31/202328610N/AN/AN/A
12/31/20222748516N/A
9/30/20222624N/AN/AN/A
6/30/20222565-65N/A
3/31/20222453N/AN/AN/A
12/31/20212405-514N/A
9/30/20212376N/AN/AN/A
6/30/20212345922N/A
3/31/20212346N/AN/AN/A
12/31/20202346719N/A
9/30/20202298N/AN/AN/A
6/30/20202296-1514N/A
3/31/20202196N/AN/AN/A
12/31/20192065-1912N/A
9/30/20191997N/AN/AN/A
6/30/20191889-1016N/A
3/31/20191889N/AN/AN/A
12/31/20181859-615N/A
9/30/201818510N/AN/AN/A
6/30/20181799N/A14N/A
3/31/20181759N/AN/AN/A
12/31/20171729N/A21N/A
9/30/20171645N/AN/AN/A
6/30/20171647N/A8N/A
3/31/20171648N/AN/AN/A
12/31/20161618N/A-1N/A
9/30/20161605N/AN/AN/A
6/30/20161595N/A8N/A
3/31/20161565N/AN/AN/A
12/31/20151579N/A13N/A
12/31/20141339N/A-13N/A
9/30/20141229N/A12N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0RB1's forecast earnings growth (25.2% per year) is above the savings rate (2.1%).

Earnings vs Market: 0RB1's earnings (25.2% per year) are forecast to grow faster than the UK market (14.6% per year).

High Growth Earnings: 0RB1's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 0RB1's revenue (8.7% per year) is forecast to grow faster than the UK market (3.5% per year).

High Growth Revenue: 0RB1's revenue (8.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 0RB1's Return on Equity is forecast to be low in 3 years time (7%).


Discover growth companies